Upgrade to see committee overlap, performance context, and full expert analysis.
AMAT congressional trades
32 matched disclosures
AMAT congressional trades snapshot
This page summarizes public STOCK Act disclosures involving AMAT. It is useful for seeing which lawmakers reported AMAT transactions, how many filings are visible, the buy/sell mix, and whether the newest public filing describes a recent or delayed trade.
Mar 6, 2026
Public House and Senate STOCK Act disclosures normalized by Congressional Trader.
Filing date can trail transaction date. This page is for research and monitoring, not investment advice.
What the AMAT congressional trade page shows
Congressional Trader tracks 32 public STOCK Act disclosures for AMATacross 12 lawmakers. This page separates purchases from sales, shows filing delays, and links each disclosure back to the individual politician profile when available.
The most recent AMAT filing shown here was filed on Mar 6, 2026 by John Boozman as a partial sale. Related lawmakers include Marjorie Taylor Greene, Markwayne Mullin, John Boozman, Jefferson Shreve, John James.
Top lawmakers for AMAT
Pro performance summary
Unlock 30/90-day post-trade summaries, committee overlap, and CSV-oriented research views for high-intent ticker research.
Compare Pro plansUpgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
FAQ
Which lawmakers traded AMAT?
Recent AMAT disclosures include Marjorie Taylor Greene, Markwayne Mullin, John Boozman, Jefferson Shreve, John James.
What is the buy/sell mix for AMAT?
The visible sample currently shows 24 purchases and 8 sales or partial sales.
Should I trade based on AMAT disclosures?
No. This page summarizes public filings for research and monitoring. It is not investment advice.